|
NSJ Bioreagents
cd45 antibody Cd45 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+Antibody/custom%40v2394%4042993085 Average 90 stars, based on 1 article reviews
cd45 antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
mouse cd45 microbeads ![]() Mouse Cd45 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+MicroBeads%2C+mouse/bio_rxiv__64898__2026__11__02__763785-51-17-20 Average 97 stars, based on 1 article reviews
mouse cd45 microbeads - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Novus Biologicals
dylight 650 ![]() Dylight 650, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+Antibody+(30-F11)+%5BDyLight+650%5D/pmc13760287-75-6-12 Average 94 stars, based on 1 article reviews
dylight 650 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Novus Biologicals
dylight 650 conjugated anti cd45 ![]() Dylight 650 Conjugated Anti Cd45, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+Antibody+(30-F11)+-+BSA+Free/pmc13760287-47-30-37 Average 93 stars, based on 1 article reviews
dylight 650 conjugated anti cd45 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
anti mouse cd45 af 647 em 05 ![]() Anti Mouse Cd45 Af 647 Em 05, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+Antibody+(EM-05)+%5BAlexa+Fluor%C2%AE+647%5D/pm42982037-856-70-75 Average 94 stars, based on 1 article reviews
anti mouse cd45 af 647 em 05 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti cd45 2 ![]() Anti Cd45 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45%2E2+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__11__03__763975-67-27-28 Average 94 stars, based on 1 article reviews
anti cd45 2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
rabbit monoclonal anti cd45 ![]() Rabbit Monoclonal Anti Cd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+Rabbit+mAb/pm42981186-194-238-241 Average 96 stars, based on 1 article reviews
rabbit monoclonal anti cd45 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Illumina Inc
genomics 1000212 cosmx human rna 1000 plex assay nanostring cmx h uscp 1kp r infiniumcoreexome 24v1 4 a1 illumina 20024662 human io panck cd45 ![]() Genomics 1000212 Cosmx Human Rna 1000 Plex Assay Nanostring Cmx H Uscp 1kp R Infiniumcoreexome 24v1 4 A1 Illumina 20024662 Human Io Panck Cd45, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/Infinium+CoreExome-24+v1%2E3+Kit/pm42986753-290-163-173 Average 94 stars, based on 1 article reviews
genomics 1000212 cosmx human rna 1000 plex assay nanostring cmx h uscp 1kp r infiniumcoreexome 24v1 4 a1 illumina 20024662 human io panck cd45 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
antibodies against human cd45 ![]() Antibodies Against Human Cd45, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/CD45+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__11__02__763650-299-18-22 Average 96 stars, based on 1 article reviews
antibodies against human cd45 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Precision X-Ray
recipient mice cd45 1 ![]() Recipient Mice Cd45 1, supplied by Precision X-Ray, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45/X-Rad320/bio_rxiv__64898__2026__10__27__762224-199-0-12 Average 98 stars, based on 1 article reviews
recipient mice cd45 1 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: Aging reshapes cardiac extravascular leukocyte transcription through bidirectional remodeling during LPS-induced endotoxemia
doi: 10.64898/2026.11.02.763785
Figure Lengend Snippet: (A) Young (9-week-old) and aged (90-week-old) mice received vehicle control or lipopolysaccharide (LPS) 24 h before euthanasia. Hearts were collected, retrogradely perfused, and enzymatically dissociated to isolate extravascular CD45⁺ cardiac immune cells. Cells were labeled with TotalSeq™ hashtag oligonucleotide (HTO) antibodies and multiplexed for single-cell RNA sequencing (scRNA-seq), with n = 4 biological replicates per experimental group at the start of the study. (B) Single-cell libraries were generated using the 10x Genomics Chromium Single Cell 3′ Gene Expression platform, followed by Illumina sequencing and Cell Ranger processing to generate gene-expression and HTO feature-barcode matrices. (C) Downstream analyses included HTO demultiplexing, hashtag-based doublet removal, quality-control (QC) filtering, clustering, and cell-type annotation. Pseudobulk differential-expression analysis using the age × LPS interaction term was subsequently performed to identify cell type-specific aging-dependent transcriptional responses to LPS. *One Aged-LPS biological replicate was excluded from downstream analysis because the mouse experienced cardiac arrest before euthanasia, representing a potential biological confounder. The final sample size analyzed was therefore n = 4 for Young-control, Young-LPS, and Aged-control groups and n = 3 for the Aged-LPS group.
Article Snippet: The cells were washed and resuspended in MACS buffer (Miltenyi Biotec), followed by enrichment of leukocytes using
Techniques: Control, Labeling, Single Cell, RNA Sequencing, Generated, Gene Expression, Illumina Sequencing, QC/EQA/Proficiency, Quantitative Proteomics, Analysis
Journal: Investigative Ophthalmology & Visual Science
Article Title: Subconjunctival Injection of Anti-Secretogranin III Mitigates Corneal Damage in Alkali Burn Injury Model
doi: 10.1167/iovs.67.13.15
Figure Lengend Snippet: Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of CD45 + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with anti-CD45 ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).
Article Snippet: The slides were then incubated with primary antibodies, including anti–fibronectin (ab2413, 1:500 dilution; Abcam, Cambridge, UK), anti–α-smooth muscle actin (α-SMA; SC56495, 1:500 dilution; Santa Cruz Biotechnology, Dallas, TX, USA), or
Techniques: Flow Cytometry, Immunofluorescence, Staining, Expressing
Journal: bioRxiv
Article Title: PERTURBATION OF THE AMINO ACID STRESS RESPONSE PATHWAY EXPOSES A METABOLIC VULNERABILITY IN MULTIPLE AGGRESSIVE CANCER SUBTYPES
doi: 10.64898/2026.11.02.763650
Figure Lengend Snippet: a. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood during treatment with ASNase (25 IU/mouse every 8 days) for 5 weeks. Treatment was discontinued following sacrifice of the vehicle-treated mice, and the remaining mice were monitored until reaching the experimental endpoint. Each dot represents an individual mouse. b. Bodyweight of mice shown in , expressed as the percentage of baseline bodyweight. Dots represent group means; error bars indicate SEM.
Article Snippet: Red blood cells were lysed using ACK lysis buffer (Gibco, #A1049201) , and remaining cells were stained using
Techniques:
Journal: bioRxiv
Article Title: PERTURBATION OF THE AMINO ACID STRESS RESPONSE PATHWAY EXPOSES A METABOLIC VULNERABILITY IN MULTIPLE AGGRESSIVE CANCER SUBTYPES
doi: 10.64898/2026.11.02.763650
Figure Lengend Snippet: a. Relative viability of leukemic cells isolated from mice treated with a single intravenous dose of ASNase (100 IU/mouse) or vehicle (n = 3 mice per group). Cells were treated ex vivo with a two-fold serial dilution of ASNase (maximum concentration 2000 mIU/mL) for 72 h before viability was assessed using CellTiter-Glo. Concentrations were log-transformed. Each dot represents the mean of three biological replicates; error bars indicate SD. b. Relative ASNS mRNA expression in leukemic cells isolated from mice in (a) treated with ASNase or vehicle. Error bars indicate SEM. **p = 0.0038 (unpaired two-tailed t-test). c. Relative ATF4 mRNA expression in leukemic cells isolated from mice in (a) treated with ASNase or vehicle. Error bars indicate SEM. *p = 0.0238 (unpaired two-tailed t-test). d. Automated capillary western blot (WES) showing ASNS protein expression in leukemic cells isolated from mice in a treated with ASNase or vehicle. β-Actin serves as the loading control. Each lane is a biological replicate. e. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood. Mice received vehicle, ASNase (25 IU/mouse, single dose; n = 3), GCN2-IN-6 (3 mg/kg, oral dose every 3.5 days; n = 3), or the combination (n = 3). No significant differences were observed between treatment groups before treatment (day 0). At day 7, all treatment groups showed reduced leukemic burden compared with vehicle (*p = 0.0300 for ASNase, **p = 0.0017 for GCN2-IN-6, ***p = 0.0009 for the combination; one-way ANOVA with Dunnett’s multiple-comparison correction). Dots represent group means; error bars indicate SEM.
Article Snippet: Red blood cells were lysed using ACK lysis buffer (Gibco, #A1049201) , and remaining cells were stained using
Techniques: Isolation, Ex Vivo, Serial Dilution, Concentration Assay, Transformation Assay, Expressing, Two Tailed Test, Automated, Western Blot, Control, Comparison
Journal: bioRxiv
Article Title: PERTURBATION OF THE AMINO ACID STRESS RESPONSE PATHWAY EXPOSES A METABOLIC VULNERABILITY IN MULTIPLE AGGRESSIVE CANCER SUBTYPES
doi: 10.64898/2026.11.02.763650
Figure Lengend Snippet: a-d. Leukemic burden, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood, in T-ALL PDX models 1–4 treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Treatment was discontinued once vehicle-treated mice reached the experimental endpoint, and the remaining mice were monitored for survival. Survival was analyzed using the Kaplan-Meier method with log-rank (Mantel-Cox) testing. Significance is indicated in the figure. e-f. Leukemic burden, measured as the percentage of human CD19-positive (hCD19⁺) cells in peripheral blood, in B-ALL PDX models 1 and 2 treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Treatment was discontinued once vehicle-treated mice reached the experimental endpoint, and the remaining mice were monitored for survival. Survival was analyzed using the Kaplan-Meier method with log-rank (Mantel-Cox) testing. Significance is indicated in the figure. g. Spleen weight of AML PDX-bearing mice treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 7 mice per group). Spleens were collected at the experimental endpoint. Statistical significance was determined using the Kruskal-Wallis test. **p = 0.0012. h. Leukemic burden, measured as the percentage of hCD45⁺ cells in peripheral blood, in the AML PDX model following treatment with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 7 mice per group). Statistical analysis was performed using a linear mixed-effects model (REML) with time and treatment as fixed effects. *p = 0.0325. i. Relative tumor growth of an ovarian cancer cell line-derived xenograft (CDX) treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Statistical analysis was performed using a linear mixed-effects model (REML). ***p = 0.0008 j. Tumor volume of a neuroblastoma PDX treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 4 per group). Statistical analysis was performed using a linear mixed-effects model (REML). ***p = 0.0002. k – n. Relative tumor growth of four TNBC PDX models treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 5 mice per group). Dots represent group means; error bars indicate SEM. Statistical analysis was performed using a linear mixed-effects model (REML). Significance is indicated in the figure.
Article Snippet: Red blood cells were lysed using ACK lysis buffer (Gibco, #A1049201) , and remaining cells were stained using
Techniques: Analysis, Derivative Assay, Xenograft Assay
Journal: bioRxiv
Article Title: Ascorbate and TET2 couple balanced hematopoiesis to disease tolerance
doi: 10.64898/2026.10.27.762224
Figure Lengend Snippet: ( A-B ) Bone marrow cellularity and the frequencies of hematopoietic stem cells, progenitors, and mature cells in bone marrow of LysMCre;Slc23a2 Δ/Δ and littermate control mice at 8 weeks of age. ( C-E ) Competitive transplant to assess ascorbate-deficient HPC-1 reconstitution function. 1,000 HPC-1 (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13 recipient mice/genotype from 3 donors/genotype). ( D-E ) Donor chimerism of myeloid progenitors in bone marrow and spleen, and mature cells in bone marrow and blood 14-15 days after transplant. ( F-G ) Competitive transplantation to assess ascorbate-deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13-14 recipient mice/genotype from 3 donors/genotype). ( G ) Donor chimerism of mature cells in bone marrow, spleen and blood 12-14 days after transplant.
Article Snippet:
Techniques: Control, Irradiation, Transplantation Assay
Journal: bioRxiv
Article Title: Ascorbate and TET2 couple balanced hematopoiesis to disease tolerance
doi: 10.64898/2026.10.27.762224
Figure Lengend Snippet: ( A ) Ascorbate enhances Tet catalytic activity and promotes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) on DNA. ( B ) 5hmC:5mC and 5mC:C ratio on DNA of sorted HSCs and progenitors from mice with the indicated genotypes. +/+ refers to littermate control mice carrying corresponding floxed alleles. ( C-D ) Frequencies of HSPCs and myeloid cells in from mice with the indicated genotypes. ( E-F ) Frequencies of erythroid progenitors in bone marrow and spleen. ( G-H ) Competitive transplantation to assess Tet2;Tet3 -deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Tet2 Δ/Δ ;Tet3 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 11-14 recipient mice/genotype from 3 donors/genotype). ( H ) Donor chimerism of mature cells in bone marrow, spleen and blood 12 days after CMP transplant.
Article Snippet:
Techniques: Activity Assay, Control, Transplantation Assay, Irradiation